Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04317417 · ClinicalTrials.gov registry record · NA
MOST EMPOWER: Optimizing An Emotion Regulation Intervention
A NA study of Cancer, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 352
- Enrollment target
- 3
- Study locations
NCT04317417: Completed NA study of Cancer, sponsored by Wake Forest University Health Sciences.
NCT04317417 is a NA study of Cancer that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 352 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (90% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04317417, a NA study of Cancer, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 352 participants
- Enrollment target
- 3
- Study locations
Study Summary
This purpose of this study is to test a digital health intervention that may promote well-being among young adult cancer survivors. Investigators hope to learn more about wellness and health-related quality of life among young adult cancer survivors by promoting well-being and teaching skills for healthy coping and mood management.
Primary Outcome
Participants completed a self-reported questionnaire on psychological well being for feelings that reflect a level of pleasurable engagement with the environment, such as happiness, joy, excitement, enthusiasm, and contentment over the past seven days. We used a mixed model to estimate the mean within-group value of the outcome (positive affect T-score) at each time point following the intervention. Average score (50): Represents the national average for the general population. 50 indicates the
Conditions Studied
Interventions
- BEHAVIORAL EMPOWER
Study Locations (3)
Illinois
- Northwestern University Feinberg School of Medicine - Chicago
North Carolina
- Wake Forest Baptist Comprehensive Cancer Center - Winston-Salem
Texas
- MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 352 participants |
| Start Date | 2022-01-06 |
| Est. Completion | 2025-04-30 |
| Phase | NA |
What the finished NCT04317417 record still lists
NCT04317417 is an interventional study that assigns participants to a tested intervention. The registered 352 participants enrollment target is mid-sized for trials with a published cap, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which EMPOWER is the first listed.
NCT04317417 reports a single indexed study location in Illinois, North Carolina, Texas.
Frequently Asked Questions
What is clinical trial NCT04317417 about?
NCT04317417 is a clinical study titled "MOST EMPOWER: Optimizing An Emotion Regulation Intervention". This purpose of this study is to test a digital health intervention that may promote well-being among young adult cancer survivors. Investigators hope to learn more about wellness and health-related quality of life among young adult cancer survivors by promoting well-being and teaching skills for he...
What is the current status of trial NCT04317417?
This trial is currently completed. It is a NA study. The enrollment target is 352 participants. The study started on 2022-01-06. Estimated completion is 2025-04-30.
What conditions does trial NCT04317417 study?
This clinical trial studies the following conditions: Cancer.
What interventions are being tested in trial NCT04317417?
The interventions under investigation include: EMPOWER (BEHAVIORAL).
Who is sponsoring clinical trial NCT04317417?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04317417 being conducted?
This trial has 3 study locations across Illinois, North Carolina, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04317417's enrollment target sits among peer trials
352 164th of 615 higher than 452 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
BfedBwell Optimization Pilot
RECRUITING · NA
-
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
RECRUITING · NA
-
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
RECRUITING · NA
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05811936 · 352 participants · NA
The SNAP Tool for Head and Neck Cancer Survivor-Caregiver Dyads
- NCT06258941 · 352 participants · Phase 1
Classroom Break, Cognition, and Fitness in Elementary School Children
- NCT06269081 · 352 participants · NA
Testing Two Interventions to Improve Health Outcomes and Quality of Life Among Rural Older Adults Living With HIV
- NCT06337292 · 352 participants · Phase 3
Incisional Negative Pressure Wound Therapy to Reduce Infection and Complications in High-Risk Fractures
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI